Get startedLog in
    Picture of Iovance Biotherapeutics logo

    IOVA — Iovance Biotherapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeLarge CapHigh Flyer
    All News

    Brief: Iovance Announces Positive Results From The First Clinical Trial For Til Cell Therapy In Soft Tissue Sarcomas

    Picture of Iovance Biotherapeutics logoIovance Biotherapeutics
    24/02/2026 12:22
    Feb 24 (Reuters) - Iovance Biotherapeutics Inc IOVA.O:

IOVANCE ANNOUNCES POSITIVE RESULTS FROM THE FIRST CLINICAL TRIAL FOR TIL CELL THERAPY IN SOFT TISSUE SARCOMAS

IOVANCE BIOTHERAPEUTICS INC: SAFETY PROFILE WAS FAVORABLE AND CONSISTENT WITH LIFILEUCEL THERAPY IN OTHER INDICATIONS

IOVANCE BIOTHERAPEUTICS INC: PLANS TO COMMENCE SINGLE ARM REGISTRATIONAL TRIAL IN SECOND-LINE ADVANCED UPS AND DDLPS IN Q2 OF 2026

Source text: ID:nGNX5tQSM

Further company coverage: IOVA.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Iovance Biotherapeutics

    See all news